Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FAVWD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,570
Award facts
- Contract value 100% obligated
- $20,569.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,569.79 by the Defense Logistics Agency on July 29, 2025, for the supply of Orencia ClickJect 125 mg/ml. This delivery order, which carries no set-aside designation, is set to be completed by July 30, 2025, with performance taking place in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's existing relationship with the federal procurement system.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The SPE2DB program vehicle enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, specializing in the distribution of prescription medications, biologics, and medical consumables to military and federal healthcare systems. Orencia ClickJect is a biologic medication used primarily in the treatment of rheumatoid arthritis and other autoimmune conditions, supporting the Defense Logistics Agency's mission to maintain adequate pharmaceutical inventory for military health services.
Quick answers
Who was awarded contract SPE2DB25FAVWD?
SPE2DB25FAVWD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FAVWD worth?
The government has obligated $20,570 on SPE2DB25FAVWD.
Is contract SPE2DB25FAVWD an order under another contract?
Yes. SPE2DB25FAVWD is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVWD competed?
The extent of competition for SPE2DB25FAVWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award